Published in Clin Exp Allergy on August 01, 2012
Development of Gene Transfer for Induction of Antigen-specific Tolerance. Mol Ther Methods Clin Dev (2014) 0.93
Detection and quantification of chimerism by droplet digital PCR. Chimerism (2013) 0.80
The site of allergen expression in hematopoietic cells determines the degree and quality of tolerance induced through molecular chimerism. Eur J Immunol (2013) 0.75
Cell Therapy for Prophylactic Tolerance in Immunoglobulin E-mediated Allergy. EBioMedicine (2016) 0.75
TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol (1989) 31.72
Production of high-titer helper-free retroviruses by transient transfection. Proc Natl Acad Sci U S A (1993) 22.33
HLA-mismatched renal transplantation without maintenance immunosuppression. N Engl J Med (2008) 7.42
IL-4 is required to generate and sustain in vivo IgE responses. J Immunol (1988) 4.04
Systemic chimerism in human female recipients of male livers. Lancet (1992) 3.63
Myeloma responses and tolerance following combined kidney and nonmyeloablative marrow transplantation: in vivo and in vitro analyses. Am J Transplant (2006) 3.34
Immunological mechanisms of allergen-specific immunotherapy. Nat Rev Immunol (2006) 2.80
Effects of retroviral vector design on expression of human adenosine deaminase in murine bone marrow transplant recipients engrafted with genetically modified cells. Proc Natl Acad Sci U S A (1995) 2.68
IFN-gamma stimulates IgG2a secretion by murine B cells stimulated with bacterial lipopolysaccharide. J Immunol (1988) 2.24
Chimerism and tolerance in a recipient of a deceased-donor liver transplant. N Engl J Med (2008) 2.22
Allogeneic bone marrow transplantation with co-stimulatory blockade induces macrochimerism and tolerance without cytoreductive host treatment. Nat Med (2000) 2.16
The regulation of immunoglobulin E class-switch recombination. Nat Rev Immunol (2003) 2.07
Immunity or tolerance: opposite outcomes of microchimerism from skin grafts. Nat Med (2001) 1.93
From allergen genes to allergy vaccines. Annu Rev Immunol (2010) 1.46
The future of antigen-specific immunotherapy of allergy. Nat Rev Immunol (2002) 1.41
Mixed chimerism and transplantation tolerance. Annu Rev Med (2001) 1.36
Treg-therapy allows mixed chimerism and transplantation tolerance without cytoreductive conditioning. Am J Transplant (2010) 1.36
The functional relevance of passenger leukocytes and microchimerism for heart allograft acceptance in the rat. Nat Med (1999) 1.35
Allergen immunotherapy. J Allergy Clin Immunol (2010) 1.26
Oral tolerance, food allergy, and immunotherapy: implications for future treatment. J Allergy Clin Immunol (2008) 1.25
Mixed chimerism, lymphocyte recovery, and evidence for early donor-specific unresponsiveness in patients receiving combined kidney and bone marrow transplantation to induce tolerance. Transplantation (2010) 1.25
Mechanisms of donor-specific tolerance in recipients of haploidentical combined bone marrow/kidney transplantation. Am J Transplant (2011) 1.17
Transplantation tolerance through mixed chimerism. Nat Rev Nephrol (2010) 1.17
The role of non-deletional tolerance mechanisms in a murine model of mixed chimerism with costimulation blockade. Am J Transplant (2005) 1.16
Antigen-fixed leukocytes tolerize Th2 responses in mouse models of allergy. J Immunol (2011) 1.13
Microchimerism maintains deletion of the donor cell-specific CD8+ T cell repertoire. J Clin Invest (2006) 1.13
Costimulation blockade inhibits allergic sensitization but does not affect established allergy in a murine model of grass pollen allergy. J Immunol (2007) 1.09
cDNA cloning of a major allergen from timothy grass (Phleum pratense) pollen; characterization of the recombinant Phl pV allergen. J Immunol (1993) 1.07
Survival and retrovirus infection of murine hematopoietic stem cells in vitro: effects of 5-FU and method of infection. Exp Hematol (1991) 1.02
Induction of T-cell tolerance to an MHC class I alloantigen by gene therapy. Blood (2002) 1.00
A hybrid molecule resembling the epitope spectrum of grass pollen for allergy vaccination. J Allergy Clin Immunol (2005) 0.99
Induction of central tolerance by mature T cells. J Immunol (2004) 0.99
Transplantation of bone marrow transduced to express self-antigen establishes deletional tolerance and permanently remits autoimmune disease. J Immunol (2008) 0.94
Induction of B-cell tolerance by retroviral gene therapy. Blood (2000) 0.92
Clinical experience with mixed chimerism to induce transplantation tolerance. Transpl Int (2008) 0.91
Animal models of protein allergenicity: potential benefits, pitfalls and challenges. Clin Exp Allergy (2009) 0.90
Tolerization of a type I allergic immune response through transplantation of genetically modified hematopoietic stem cells. J Immunol (2008) 0.89
Mediator release assays based on human or murine immunoglobulin E in allergen standardization. Clin Exp Allergy (2007) 0.89
Induction of central deletional T cell tolerance by gene therapy. J Immunol (2002) 0.86
Gene therapy progress and prospects: gene therapy in organ transplantation. Gene Ther (2003) 0.86
Persistence of antigen is required to maintain transplantation tolerance induced by genetic modification of bone marrow stem cells. Am J Transplant (2006) 0.86
Gene therapy to inhibit xenoantibody production using lentiviral vectors in non-human primates. Gene Ther (2006) 0.86
Combination vaccines for the treatment of grass pollen allergy consisting of genetically engineered hybrid molecules with increased immunogenicity. FASEB J (2002) 0.85
Induction of alloreactive CD4 T cell tolerance in molecular chimeras: a possible role for regulatory T cells. J Immunol (2006) 0.85
A hypoallergenic hybrid molecule with increased immunogenicity consisting of derivatives of the major grass pollen allergens, Phl p 2 and Phl p 6. Biol Chem (2008) 0.81
Gene therapy: progress in childhood disease. J Paediatr Child Health (2011) 0.80
Inducing mixed chimerism and transplantation tolerance through allogeneic bone marrow transplantation with costimulation blockade. Methods Mol Biol (2007) 0.80
Expression of a major plant allergen as membrane-anchored and secreted protein in human cells with preserved T cell and B cell epitopes. Int Arch Allergy Immunol (2011) 0.80
T cells mediate resistance to genetically modified bone marrow in lethally irradiated recipients. Transplantation (2002) 0.80
Gene therapy and bone marrow stem-cell transfer to treat autoimmune disease. Trends Mol Med (2009) 0.77
A chimerism-based approach to induce tolerance in IgE-mediated allergy. Crit Rev Immunol (2009) 0.77
RAG-1-deficient mice have no mature B and T lymphocytes. Cell (1992) 20.97
Mutations in T-cell antigen receptor genes alpha and beta block thymocyte development at different stages. Nature (1992) 7.66
T cell receptor delta gene mutant mice: independent generation of alpha beta T cells and programmed rearrangements of gamma delta TCR genes. Cell (1993) 4.18
Practical guide to skin prick tests in allergy to aeroallergens. Allergy (2011) 2.51
Antibodies induced with recombinant VP1 from human rhinovirus exhibit cross-neutralisation. Eur Respir J (2010) 2.19
Allergic Rhinitis and its Impact on Asthma (ARIA): achievements in 10 years and future needs. J Allergy Clin Immunol (2012) 2.17
Allergen-specific immunotherapy with a monophosphoryl lipid A-adjuvanted vaccine: reduced seasonally boosted immunoglobulin E production and inhibition of basophil histamine release by therapy-induced blocking antibodies. Clin Exp Allergy (2003) 2.08
The gene coding for the major birch pollen allergen Betv1, is highly homologous to a pea disease resistance response gene. EMBO J (1989) 1.93
Factors responsible for differences between asymptomatic subjects and patients presenting an IgE sensitization to allergens. A GA2LEN project. Allergy (2006) 1.84
Microinjected profilin affects cytoplasmic streaming in plant cells by rapidly depolymerizing actin microfilaments. Curr Biol (1994) 1.70
Allergen immunotherapy: therapeutic vaccines for allergic diseases. World Health Organization. American academy of Allergy, Asthma and Immunology. Ann Allergy Asthma Immunol (1998) 1.70
The MIM complex mediates preprotein translocation across the mitochondrial inner membrane and couples it to the mt-Hsp70/ATP driving system. Cell (1995) 1.63
Basophils are not the key antigen-presenting cells in allergic patients. Allergy (2012) 1.57
The profilin multigene family of maize: differential expression of three isoforms. Plant J (1993) 1.56
Prevention of latex allergy by selection of low-allergen gloves. Clin Exp Allergy (2000) 1.55
Vaccines for birch pollen allergy based on genetically engineered hypoallergenic derivatives of the major birch pollen allergen, Bet v 1. Clin Exp Allergy (2004) 1.55
Vaccination with genetically engineered allergens prevents progression of allergic disease. Proc Natl Acad Sci U S A (2004) 1.53
Belatacept-based immunosuppression in de novo liver transplant recipients: 1-year experience from a phase II randomized study. Am J Transplant (2014) 1.50
Prophylactic and therapeutic vaccination with carrier-bound Bet v 1 peptides lacking allergen-specific T cell epitopes reduces Bet v 1-specific T cell responses via blocking antibodies in a murine model for birch pollen allergy. Clin Exp Allergy (2014) 1.45
Waking the dead. Lancet (2001) 1.39
Treg-therapy allows mixed chimerism and transplantation tolerance without cytoreductive conditioning. Am J Transplant (2010) 1.36
Recombinant allergens for allergen-specific immunotherapy: 10 years anniversary of immunotherapy with recombinant allergens. Allergy (2011) 1.31
Unfolding of preproteins upon import into mitochondria. EMBO J (1998) 1.30
Variability of IgE reactivity profiles among European mite allergic patients. Eur J Clin Invest (2008) 1.29
Peripheral lymphoid development and function in TCR mutant mice. Int Immunol (1994) 1.26
MeDALL (Mechanisms of the Development of ALLergy): an integrated approach from phenotypes to systems medicine. Allergy (2011) 1.22
Conversion of the major birch pollen allergen, Bet v 1, into two nonanaphylactic T cell epitope-containing fragments: candidates for a novel form of specific immunotherapy. J Clin Invest (1997) 1.22
Nonanaphylactic synthetic peptides derived from B cell epitopes of the major grass pollen allergen, Phl p 1, for allergy vaccination. FASEB J (2001) 1.21
Developments in allergen-specific immunotherapy: from allergen extracts to allergy vaccines bypassing allergen-specific immunoglobulin E and T cell reactivity. Clin Exp Allergy (2010) 1.20
Important research questions in allergy and related diseases: nonallergic rhinitis: a GA2LEN paper. Allergy (2008) 1.20
The molecular basis for allergen cross-reactivity: crystal structure and IgE-epitope mapping of birch pollen profilin. Structure (1997) 1.18
Induction of antibody responses to new B cell epitopes indicates vaccination character of allergen immunotherapy. Eur J Immunol (1999) 1.17
Tolerization of anti-Galalpha1-3Gal natural antibody-forming B cells by induction of mixed chimerism. J Exp Med (1998) 1.17
Heterogeneity of commercial timothy grass pollen extracts. Clin Exp Allergy (2008) 1.16
Component-resolved diagnosis of house-dust mite allergy with purified natural and recombinant mite allergens. Clin Exp Allergy (2004) 1.15
Molecular characterization of Der p 10: a diagnostic marker for broad sensitization in house dust mite allergy. Clin Exp Allergy (2011) 1.14
Interaction of plant profilin with mammalian actin. Eur J Biochem (1994) 1.13
Clinical effects of immunotherapy with genetically modified recombinant birch pollen Bet v 1 derivatives. Clin Exp Allergy (2008) 1.12
Degradation of a short-lived glycoprotein from the lumen of the endoplasmic reticulum: the role of N-linked glycans and the unfolded protein response. Mol Biol Cell (1999) 1.11
Immunotherapy of allergic disease. Adv Immunol (2004) 1.10
Common epitopes of birch pollen and apples--studies by western and northern blot. J Allergy Clin Immunol (1991) 1.09
Genetic engineering of a hypoallergenic trimer of the major birch pollen allergen Bet v 1. FASEB J (2001) 1.08
IgE antibodies to recombinant pollen allergens (Phl p 1, Phl p 2, Phl p 5, and Bet v 2) account for a high percentage of grass pollen-specific IgE. J Allergy Clin Immunol (1998) 1.07
Molecular and immunological characterization of arginine kinase from the Indianmeal moth, Plodia interpunctella, a novel cross-reactive invertebrate pan-allergen. J Immunol (2001) 1.06
Identification of allergens in fruits and vegetables: IgE cross-reactivities with the important birch pollen allergens Bet v 1 and Bet v 2 (birch profilin). J Allergy Clin Immunol (1995) 1.06
Plant and animal profilins are functionally equivalent and stabilize microfilaments in living animal cells. J Cell Sci (1996) 1.06
Human IgG monoclonal antibodies that modulate the binding of specific IgE to birch pollen Bet v 1. J Immunol (1996) 1.04
Microarrayed recombinant allergens for diagnosis of allergy. Clin Exp Allergy (2003) 1.01
Different allergenic activity of grass pollen allergens revealed by skin testing. Eur J Clin Invest (2008) 1.01
Characterization of Der p 21, a new important allergen derived from the gut of house dust mites. Allergy (2008) 1.01
Quantitative IgE inhibition experiments with purified recombinant allergens indicate pollen-derived allergens as the sensitizing agents responsible for many forms of plant food allergy. J Allergy Clin Immunol (2000) 1.01
Ensemble modelling of nutrient loads and nutrient load partitioning in 17 European catchments. J Environ Monit (2009) 1.01
Identification of multiple T cell epitopes on Bet v I, the major birch pollen allergen, using specific T cell clones and overlapping peptides. J Immunol (1993) 1.00
Cigarette smoke facilitates allergen penetration across respiratory epithelium. Allergy (2008) 0.99
Molecular composition and biological activity of commercial birch pollen allergen extracts. Eur J Clin Invest (2009) 0.99
T cell epitope-containing hypoallergenic recombinant fragments of the major birch pollen allergen, Bet v 1, induce blocking antibodies. J Immunol (2000) 0.98
Non-anaphylactic surface-exposed peptides of the major birch pollen allergen, Bet v 1, for preventive vaccination. Clin Exp Allergy (2004) 0.98
Expression of mast cell tryptase by myeloblasts in a group of patients with acute myeloid leukemia. Blood (2001) 0.98
Birch pollen rupture and the release of aerosols of respirable allergens. Clin Exp Allergy (2004) 0.97
Isolation of cDNA clones coding for IgE autoantigens with serum IgE from atopic dermatitis patients. FASEB J (1998) 0.97
Recombinant allergen-based monitoring of antibody responses during injection grass pollen immunotherapy and after 5 years of discontinuation. Allergy (2011) 0.97
Intranasal treatment with a recombinant hypoallergenic derivative of the major birch pollen allergen Bet v 1 prevents allergic sensitization and airway inflammation in mice. Int Arch Allergy Immunol (2001) 0.97
Clinical improvement and immunological changes in atopic dermatitis patients undergoing subcutaneous immunotherapy with a house dust mite allergoid: a pilot study. Clin Exp Allergy (2007) 0.96
Molecular cloning and characterization of profilin from tobacco (Nicotiana tabacum): increased profilin expression during pollen maturation. Plant Mol Biol (1995) 0.96
Severe chronic allergic (and related) diseases: a uniform approach--a MeDALL--GA2LEN--ARIA position paper. Int Arch Allergy Immunol (2012) 0.96
Molecular characterization of Bip 1, a monoclonal antibody that modulates IgE binding to birch pollen allergen, Bet v 1. J Immunol (1996) 0.95
Identification of common allergenic structures in hazel pollen and hazelnuts: a possible explanation for sensitivity to hazelnuts in patients allergic to tree pollen. J Allergy Clin Immunol (1992) 0.95
Micro-arrayed wheat seed and grass pollen allergens for component-resolved diagnosis. Allergy (2009) 0.95
Carrier-bound Alt a 1 peptides without allergenic activity for vaccination against Alternaria alternata allergy. Clin Exp Allergy (2012) 0.95
Construction of a combinatorial IgE library from an allergic patient. Isolation and characterization of human IgE Fabs with specificity for the major timothy grass pollen allergen, Phl p 5. J Biol Chem (1996) 0.95
B cell epitopes of the major timothy grass pollen allergen, phl p 1, revealed by gene fragmentation as candidates for immunotherapy. FASEB J (1999) 0.95
Inhibition of CD26 peptidase activity significantly improves engraftment of retrovirally transduced hematopoietic progenitors. Gene Ther (2006) 0.95
Analysis of the sensitization profile towards allergens in central Africa. Clin Exp Allergy (2003) 0.95
Identification of common allergenic structures in mugwort and ragweed pollen. J Allergy Clin Immunol (1998) 0.95
IgE cross-reactivities against albumins in patients allergic to animals. J Allergy Clin Immunol (1995) 0.93
Immunologic characterization of purified recombinant timothy grass pollen (Phleum pratense) allergens (Phl p 1, Phl p2, Phl p 5). J Allergy Clin Immunol (1996) 0.93
Isolation of an immunodominant IgE hapten from an epitope expression cDNA library. Dissection of the allergic effector reaction. J Biol Chem (1994) 0.93
Inhibition of xenoreactive natural antibody production by retroviral gene therapy. Science (1998) 0.93
Molecular, immunological, and structural characterization of Phl p 6, a major allergen and P-particle-associated protein from Timothy grass (Phleum pratense) pollen. J Immunol (1999) 0.92
Radiation inducible DNA repair processes in eukaryotes. Biochimie (1999) 0.92
T-cell epitopes of Phl p 1, major pollen allergen of timothy grass (Phleum pratense): evidence for crossreacting and non-crossreacting T-cell epitopes within grass group I allergens. J Allergy Clin Immunol (1995) 0.92
Induction of B-cell tolerance by retroviral gene therapy. Blood (2000) 0.92
Carrier-bound nonallergenic Der p 2 peptides induce IgG antibodies blocking allergen-induced basophil activation in allergic patients. Allergy (2012) 0.92
Critical role of proinflammatory cytokine IL-6 in allograft rejection and tolerance. Am J Transplant (2011) 0.92
Properties of tree and grass pollen allergens: reinvestigation of the linkage between solubility and allergenicity. Int Arch Allergy Immunol (1993) 0.92
A critical role for interleukin 4 in activating alloreactive CD4 T cells. Nat Immunol (2000) 0.91
Mechanisms involved in the establishment of tolerance through costimulatory blockade and BMT: lack of requirement for CD40L-mediated signaling for tolerance or deletion of donor-reactive CD4+ cells. Am J Transplant (2001) 0.90
Inhibition of CD23-dependent facilitated allergen binding to B cells following vaccination with genetically modified hypoallergenic Bet v 1 molecules. Clin Exp Allergy (2010) 0.90
Analysis of the antibody responses induced by subcutaneous injection immunotherapy with birch and Fagales pollen extracts adsorbed onto aluminum hydroxide. Int Arch Allergy Immunol (2009) 0.90
Molecular cloning and mRNA localization of tomato pollen profilin. Plant Mol Biol (1998) 0.90
Release of allergen-bearing cytoplasm from hydrated pollen: a mechanism common to a variety of grass (Poaceae) species revealed by electron microscopy. J Allergy Clin Immunol (2001) 0.90
Detection of an allergen in dog dander that cross-reacts with the major cat allergen, Fel d 1. Clin Exp Allergy (2007) 0.89
Dissociation of allergen-specific IgE and IgA responses in sera and tears of pollen-allergic patients: a study performed with purified recombinant pollen allergens. J Allergy Clin Immunol (2000) 0.89
Resistance to ABT-737 in activated T lymphocytes: molecular mechanisms and reversibility by inhibition of the calcineurin-NFAT pathway. Cell Death Dis (2012) 0.89